Literature DB >> 21352822

Neuropeptide Y receptors in carotid plaques of symptomatic and asymptomatic patients: effect of inflammatory cytokines.

Divya Pankajakshan1, Guanghong Jia, Iraklis Pipinos, Steve H Tyndall, Devendra K Agrawal.   

Abstract

AIMS: Cytokines released by the immune cells at the site of plaque milieu induce smooth muscle cell apoptosis to promote plaque instability. But, neuropeptide Y (NPY), a pleotropic factor, may modulate the effects of cytokines in atherosclerotic plaques of patients with carotid stenosis. Our aim was to investigate the relative expression of NPY-Y1, NPY-Y2 and NPY-Y5 receptors on carotid plaque vascular smooth muscle cells (pVSMCs) of symptomatic (S) and asymptomatic (AS) patients and examine the effect of inflammatory cytokines on the expression of NPY receptors, that may attenuate plaque rupture. METHODS AND
RESULTS: In healthy carotid artery, there were significantly increased immunopositivity and increased mRNA transcripts of NPY-Y1 and NPY-Y5 receptors in thin sections and isolated VSMCs, respectively, compared to S and AS plaques. However, the NPY-Y2 expression was higher in S and AS pVSMCs than controls. Stimulation of the cells with TNF-α, IL-12 or IFN-γ (50 ng/ml) decreased mRNA transcripts of NPY-Y1 and NPY-Y5 and increased NPY-Y2 mRNAs in VSMCs of healthy carotid artery. The effect of the cytokines on mRNA transcripts of NPY-Y5 and NPY-Y2 in pVSMCs of S and AS patients was similar to healthy VSMCs, but with variable effect on NPY-Y1.
CONCLUSION: Increased expression of NPY-Y2 receptors in symptomatic pVSMCs than in healthy and asymptomatic subjects suggests a potential role of NPY-Y2 in plaque instability. This is further supported by the pronounced effect of atheroma-associated cytokines to increase NPY-Y2 mRNA transcripts in pVSMCs of patients with carotid stenosis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352822      PMCID: PMC3091977          DOI: 10.1016/j.yexmp.2011.02.005

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  23 in total

1.  Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors.

Authors:  Sharareh Movafagh; John P Hobson; Sarah Spiegel; Hynda K Kleinman; Zofia Zukowska
Journal:  FASEB J       Date:  2006-08-04       Impact factor: 5.191

2.  Increased expression of inhibitor of apoptosis proteins in atherosclerotic plaques of symptomatic patients with carotid stenosis.

Authors:  Edward P Moran; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2007-01-17       Impact factor: 3.362

3.  Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors.

Authors:  Lijun Li; Ann-Cathrine Jönsson-Rylander; Ken Abe; Zofia Zukowska
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-07-28       Impact factor: 8.311

Review 4.  Cytokines in atherosclerosis: pathogenic and regulatory pathways.

Authors:  Alain Tedgui; Ziad Mallat
Journal:  Physiol Rev       Date:  2006-04       Impact factor: 37.312

5.  Neuropeptide Y stimulates DNA synthesis in human vascular smooth muscle cells through neuropeptide Y Y1 receptors.

Authors:  T Nilsson; L Edvinsson
Journal:  Can J Physiol Pharmacol       Date:  2000-03       Impact factor: 2.273

6.  Factors associated with apoptosis in symptomatic and asymptomatic carotid atherosclerotic plaques.

Authors:  L Artese; S Ucchino; A Piattelli; M Piccirilli; V Perrotti; A Mezzetti; F Cipollone
Journal:  Int J Immunopathol Pharmacol       Date:  2005 Oct-Dec       Impact factor: 3.219

Review 7.  Clinical potentials of neuropeptide Y family of hormones.

Authors:  Ambikaipakan Balasubramaniam
Journal:  Am J Surg       Date:  2002-04       Impact factor: 2.565

8.  Inability of vascular smooth muscle cells to proceed beyond S phase of cell cycle, and increased apoptosis in symptomatic carotid artery disease.

Authors:  Ashwini S Dhume; Devendra K Agrawal
Journal:  J Vasc Surg       Date:  2003-07       Impact factor: 4.268

9.  Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium.

Authors:  Z Zukowska-Grojec; E Karwatowska-Prokopczuk; W Rose; J Rone; S Movafagh; H Ji; Y Yeh; W T Chen; H K Kleinman; E Grouzmann; D S Grant
Journal:  Circ Res       Date:  1998-07-27       Impact factor: 17.367

10.  Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.

Authors:  Edward W Lee; Mieczyslaw Michalkiewicz; Joanna Kitlinska; Ivana Kalezic; Hanna Switalska; Peter Yoo; Amarin Sangkharat; Hong Ji; Lijun Li; Teresa Michalkiewicz; Milos Ljubisavljevic; Hakan Johansson; Derrick S Grant; Zofia Zukowska
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.